Shopping Cart
- Remove All
- Your shopping cart is currently empty
Recifercept (TA-46) is a recombinant human soluble fibroblast growth factor receptor 3, a decoy protein that competes for the ligand of mutant FGFR3.Recifercept is used in the study of chondrodysplasia because it restores normal bone growth by preventing negative inhibitory signaling of mutant FGFR3 in patients with pediatric chondrodysplasia.Recifercept is a recombinant human recombinant fibroblast growth factor receptor 3 that competes for the ligand of mutant FGFR3.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $328 | In Stock | |
5 mg | $859 | In Stock | |
10 mg | $1,370 | In Stock |
Description | Recifercept (TA-46) is a recombinant human soluble fibroblast growth factor receptor 3, a decoy protein that competes for the ligand of mutant FGFR3.Recifercept is used in the study of chondrodysplasia because it restores normal bone growth by preventing negative inhibitory signaling of mutant FGFR3 in patients with pediatric chondrodysplasia.Recifercept is a recombinant human recombinant fibroblast growth factor receptor 3 that competes for the ligand of mutant FGFR3. |
Alias | TA-46, TA46, sFGFR3, PF-07256472, PF07256472 |
Cas No. | 2226238-09-9 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.